no statement of use filed
on 06 Mar 2023
Last Applicant/ Owned by
235 East 42nd Street
New York
NY
10017
Serial Number
90898810 filed on 24th Aug 2021
Registration Number
N/A
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disor Read More
Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use; pharmaceutical preparations for cholesterol level reduction; pharmaceutical preparations for triglyceride level reduction
No 90898810
No Service/Collective Mark
No
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
06th Mar 2023 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
06th Mar 2023 | ABANDONMENT - NO USE STATEMENT FILED |
02th Aug 2022 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
07th Jun 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
07th Jun 2022 | PUBLISHED FOR OPPOSITION |
18th May 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
05th May 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
05th May 2022 | ASSIGNED TO EXAMINER |
10th Oct 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
27th Aug 2021 | NEW APPLICATION ENTERED |